361 related articles for article (PubMed ID: 17241687)
41. Lung adenocarcinoma associated with atypical adenomatous hyperplasia. A clinicopathological study with special reference to smoking and cancer multiplicity.
Kitagawa H; Goto A; Niki T; Hironaka M; Nakajima J; Fukayama M
Pathol Int; 2003 Dec; 53(12):823-7. PubMed ID: 14629747
[TBL] [Abstract][Full Text] [Related]
42. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
43. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
44. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
[TBL] [Abstract][Full Text] [Related]
45. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal numerical abnormalities in early stage lung adenocarcinoma.
Sano T; Kitayama Y; Igarashi H; Suzuki M; Tanioka F; Chida K; Okudela K; Sugimura H
Pathol Int; 2006 Mar; 56(3):117-25. PubMed ID: 16497244
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
48. Bronchioloalveolar neoplasia.
Kitamura H; Okudela K
Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
[TBL] [Abstract][Full Text] [Related]
49. The utility of B72.3, carcinoembryonic antigen, and Leu M-1 in cell blocks: an adjunct to fine-needle aspiration diagnosis of bronchioloalveolar carcinoma of the lung.
Chandan VS; Truong LD; Khurana KK
Cancer; 2005 Aug; 105(4):246-52. PubMed ID: 15971208
[TBL] [Abstract][Full Text] [Related]
50. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426
[TBL] [Abstract][Full Text] [Related]
51. Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
Pastorino U; Calabrò E; Tamborini E; Marchianò A; Orsenigo M; Fabbri A; Sozzi G; Novello S; De Marinis F
J Thorac Oncol; 2009 Feb; 4(2):266-7. PubMed ID: 19179908
[TBL] [Abstract][Full Text] [Related]
52. Alveolar cell hyperplasia in association with adenocarcinoma of lung.
Rao SK; Fraire AE
Mod Pathol; 1995 Feb; 8(2):165-9. PubMed ID: 7777478
[TBL] [Abstract][Full Text] [Related]
53. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
[TBL] [Abstract][Full Text] [Related]
54. Lung carcinoma-associated atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa.
Kayser K; Kosjerina Z; Goldmann T; Kayser G; Kazmierczak B; Vollmer E
Lung Cancer; 2005 Feb; 47(2):205-14. PubMed ID: 15639719
[TBL] [Abstract][Full Text] [Related]
55. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S
Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960
[TBL] [Abstract][Full Text] [Related]
57. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
58. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
[TBL] [Abstract][Full Text] [Related]
59. [Preneoplastic lesions of pulmonary carcinoma].
Bubendorf L
Pathologe; 2011 Nov; 32 Suppl 2():218-23. PubMed ID: 22033683
[TBL] [Abstract][Full Text] [Related]
60. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
